Shane Patella ANZBMS-MEPSA-ANZORS 2022

Abstracts this author is presenting:

• IPN60130 for the treatment of fibrodysplasia ossificans progressiva: Methodology of the randomized, double-blind, placebo-controlled phase II FALKON trial — ANZBMS-MEPSA-ANZORS Poster Listing: Clinical
• Palovarotene for the treatment of Fibrodysplasia Ossificans Progressiva: Methodology of the phase III open-label PIVOINE rollover trial — ANZBMS-MEPSA-ANZORS Poster Listing: Clinical
• Joint function and quality of life in Fibrodysplasia Ossificans Progressiva: Results from an international burden of illness survey of patients and family members — ANZBMS-MEPSA-ANZORS Poster Listing: Clinical